Form D · Pharmaceuticals
Zosano Pharma Corp
Fremont, CA · CIK 0001587221
Offering snapshot reported Aug 29, 2016 · SEC filing
- Reported sold
- $7.54M Offering amount: $7.54M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 29, 2016 | Initial | $7,536,000 | No comparison | 18 | SEC filing |
| Jun 30, 2015 | Initial | $0 | No comparison | 1 | SEC filing |
| Feb 3, 2015 | Initial | $14,999,996 | No comparison | 1 | SEC filing |
| Dec 4, 2014 | Initial | $1,333,000 | No comparison | 2 | SEC filing |
| Mar 5, 2014 | Initial | $2,500,000 | No comparison | 3 | SEC filing |
| Sep 20, 2013 | Initial | $3,033,723 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $528K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-269677
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Guggenheim Securities, LLC | 40638 | |
| Roth Capital Partners, LLC | 15407 |
Source: Form D, filed Aug 29, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Konstantinos Alataris | Director, Executive |
| James Barrett | Director |
| M. James Barrett | Director |
| Peter Daddona | Director, Executive |
| Georgia Erbez | Executive |
| Joseph P. Hagan | Director |
| Donald Kellerman | Executive |
| Christopher Krueger | Executive |
| Vikram Lamba | Director, Executive |
| Haley Lewis | Executive |
| Nandan Oza | Executive |
| Laxmi Peri | Executive |
| John Richard | Director |
| Eric Scharin | Executive |
| Bruce D. Steel | Director |
| Winnie Tso | Executive |
| Thorsten Von Stein | Executive |
| John Walker | Director |
| Troy Wilson | Director |
| Kleanthis Xanthopoulos | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
34790 Ardentech Court
Fremont, CA, 94555
Fremont, CA, 94555